Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: EDAP

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Earnings

Earnings Scheduled For May 17, 2023

By Benzinga Insights
May 17, 8:06 AM
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is likely to report quarterly earnings at $0.14 per share on revenue of $369.35 million.

AIH

Read More
1 minute read
  • Earnings

Recap: Edap TMS Q1 Earnings

By Benzinga Insights
May 17, 6:45 AM
Edap TMS (NASDAQ:EDAP) reported its Q1 earnings results on Wednesday, May 17, 2023 at 06:30 AM. Here’s what…

EDAP

Read More
1 minute read
  • Earnings

Edap TMS Earnings Preview

By Benzinga Insights
May 16, 11:03 AM
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Wednesday, 2023-05-17. Here’s what investors…

EDAP

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights
April 6, 9:06 AM
Gainers VistaGen Therapeutics (NASDAQ:VTGN) stock moved upwards by 22.8% to $0.16 during Thursday’s pre-market session. The market value…

ARDS

Read More
6 minute read
  • Earnings

Earnings Scheduled For March 30, 2023

By Benzinga Insights
March 30, 7:24 AM
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

AACG

Read More
1 minute read
  • Earnings

Edap TMS’s Earnings: A Preview

By Benzinga Insights
March 29, 11:02 AM
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Thursday, 2023-03-30. Here’s what investors…

EDAP

Read More
1 minute read
  • Earnings

Edap TMS’s Earnings: A Preview

By Benzinga Insights
March 29, 11:02 AM
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Thursday, 2023-03-30. Here’s what investors…

EDAP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $13

By Benzinga Newsdesk
February 15, 7:08 AM
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Edap TMS (NASDAQ:EDAP) with a Buy and raises the price target from $12 to $13.

EDAP

Read More
1 minute read
  • Biotech
  • General
  • News

EDAP Announces Approval To Initiate Randomized Clinical Trial Evaluating Focal One As Potential Treatment For Rectal Deep Infiltrating Endometriosis

By Michael Horton
November 30, 5:07 PM
EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic therapeutic ultrasound, today announced that the Company has received approval from French authorities to initiate a Phase 3 randomized,

EDAP

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

HC Wainwright & Co. Maintains Buy on Edap TMS, Raises Price Target to $12

By Benzinga Newsdesk
November 18, 7:22 AM
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Edap TMS (NASDAQ:EDAP) with a Buy and raises the price target from $11 to $12.

EDAP

Posts navigation

1 2 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service